- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Seth H. Lundy
Events 20 results
Webinar
February 24, 2022
Navigating the Future: Considerations Related to “Femtech” and Other Digital Health Tools
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Speaking Engagement
November 2, 2021
Craig Carpenito, Dixie Johnson, Nikki Reeves, Seth Lundy to Speak at Virtual 22nd Annual Pharmaceutical and Medical Device Ethics and Compliance Congress
Webinar
September 9, 2021
14th Annual King & Spalding Medical Device Summit
Webinar
November 10, 2020
13th Annual King & Spalding Medical Device Summit
Speaking Engagement
August 10, 2020
Seth Lundy to Speak at 17th Annual CBI Pharmaceutical Compliance Congress
Speaking Engagement
August 6, 2020
Seth Lundy, Brian Bohnenkamp, Gina Cavalier, Terrence Burek to Speak on Webinar About Compliance in the Time of COVID
Conference
November 12, 2019
12th Annual King & Spalding Pharmaceutical University
Speaking Engagement
October 22, 2019
Seth Lundy, Jason Jones to Speak at MedTrade Fall Conference
Conference
June 21, 2018
West Coast Pharmaceutical & Medical Device University
Webinar
April 6, 2017
Managed Care Contracting Risks: An Antitrust, Government Pricing, and Fraud and Abuse Analysis
Conference
January 12, 2017
An Introduction to the 21st Century Cures Act